-+ 0.00%
-+ 0.00%
-+ 0.00%

HOTH THERAPEUTICS HT-001 INTERIM RESULTS FIRST-IN-CLASS TOPICAL THERAPY PRESERVES CANCER TREATMENT WHILE RESOLVING DERMATOLOGIC SIDE EFFECTS

Reuters·06/24/2025 14:36:30

Please log in to view news